Invasive pulmonary aspergillosis in a patient with metastatic non-small cell lung cancer after treatment with gefitinib

Korean J Intern Med. 2018 Jan;33(1):211-213. doi: 10.3904/kjim.2015.276. Epub 2016 Nov 25.

Authors

Sejeong Park¹, Soyoung Park¹, Hana Choi¹, Ji Young Park¹, Hyo Seok Lim¹, Myung Jae Park¹, Si-Young Kim²

Affiliations

¹ Department of Pulmonary and Critical Care Medicine, Kyung Hee University Medical Center, Seoul, Korea.
² Department of Hematology-Oncology, Kyung Hee University Medical Center, Seoul, Korea.

No abstract available

Keywords: Carcinoma, non-small-cell lung; Gefitinib; Invasive pulmonary aspergillosis.

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents / adverse effects*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / genetics
ErbB Receptors / genetics
Fatal Outcome
Gefitinib / adverse effects*
Humans
Invasive Pulmonary Aspergillosis / chemically induced*
Invasive Pulmonary Aspergillosis / diagnostic imaging
Lung Neoplasms / drug therapy*
Lung Neoplasms / genetics
Male
Middle Aged
Prospective Studies

Substances

Antineoplastic Agents
ErbB Receptors
Gefitinib